Elucidating the function of clusterin in the progression of diabetic kidney disease
Diabetic kidney disease (DKD) is a common microvascular complication and the main cause of death in diabetic patients. Metabolic disorders can accelerate the occurrence and development of DKD through a variety of ways, Recent studies have found that Clusterin (Clu) levels are associated with renal d...
Saved in:
| Main Authors: | Lin Mao, Ruili Yin, Longyan Yang, Dong Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1573654/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease
by: Anqi Feng, et al.
Published: (2025-04-01) -
Clusterin ameliorates diabetic atherosclerosis by suppressing macrophage pyroptosis and activation
by: Lingling Xuan, et al.
Published: (2025-04-01) -
Urinary Clusterin is a Biomarker of Renal Epithelial Senescence and Predicts Human Kidney Disease Progression
by: David P. Baird, et al.
Published: (2025-07-01) -
Curcumin-Induced Apoptotic Cell Death in Human Glioma Cells Is Enhanced by Clusterin Deficiency
by: Pinky Sultana, et al.
Published: (2025-05-01) -
Clusterin deficiency exacerbates cholestatic liver disease through ER stress and NLRP3 inflammasome activation
by: Hye-Young Seo, et al.
Published: (2025-03-01)